Nextbiotics, founded with a mission to harness the power of viruses for beneficial applications, operates as a biotechnology platform focused on engineering viruses for good. The company aims to revolutionize healthcare and environmental solutions by developing viral-based technologies that can target and eliminate harmful bacteria, offering an innovative approach to combating antibiotic resistance and other microbial threats.
Affiliated with leading experts in virology and biotechnology, Nextbiotics has garnered attention from prominent investors in the biotech sector. The company has achieved significant milestones in its research and development efforts, demonstrating the efficacy of its engineered viruses in preclinical trials. By pioneering this novel approach, Nextbiotics is poised to make a substantial impact on public health and environmental sustainability.
